[ad_1]
Scientists have found acute myeloid leukemia (AML), an aggressive form of the immune cell, a blood test could detect a person's leukemia risk at least five years before they develop cancer. almost always prefaced by certain genetic changes in the bloodstream.
Currently, physicians would be hard-pressed to prevent the progression of leukemia even if they did not start it because they did not have such treatment.
hard-to-treat cancer, allowing doctors to monitor patients' risks in the same way that polyps and moles can be red flags for colon or skin cancers.
The findings could be a game-changer for the hard-to-treat blood cancer, allowing doctors to monitor patients' risks in the same way that polyps can be red flags for colon cancers [19659008] 'Acute myeloid leukemia often appears very suddenly in patients, so we are surprised to discover that its origins are detectable more than five years before the disease develops,' said joint first author Dr. Grace Collord from the Wellcome Sanger Institute and University of Cambridge.
'This provides proof-of-principle that it may be possible to develop tests to identify people at a high risk of developing AML.'
Leukemia is cancer of the white blood cells, which are key fighting infections
Acute myeloid leukemia (AML) is a particularly aggressive form of the disease. It starts in the bone marrow, stopping the production of normal blood cells, leading to fatal infections and bleeding.
AML is rare. Around 2,600 Britons are diagnosed a year, and 19,520 Americans – accounting for about one percent of each nation's respective cancer rate.
It is possible that they are rapidly developing and their survival rates are low.
Mainstream treatments for AML for the treatment of myeloid leukemia (AML) is a type of cancer
WHAT IS ACUTE MYELOID LEUKEMIA? of the blood and bone marrow with excess immature white blood cells.
Most cases developed from cells that would turn into white blood cells (other than lymphocytes), but some cases of AML developed in other types of blood-forming cells.
AML it quickly moves into the blood.
AML progresses rapidly, with myeloid cells interfering with the production of normal white blood cells, red blood cells, and platelets.
Treatments include chemotherapy, other drug
American Cancer Society
